Xspray-logo-white
  • Home
  • About us
    • Business model
    • Our history – a timeline
    • Board of Directors & Board committees
    • Management
  • Technology
  • Pipeline
  • Media
  • Contact
  • Investors
  • en en
    • sv sv
  • Investors
    • Share information
      • Ownership structure
    • Financial calendar
    • Financial reports
      • ESEF report
    • Prospectus
    • Press releases
    • Corporate governance
      • Corporate Structure
      • General meetings
      • Corporate Governance Reports
      • Nomination committee
      • Board of Directors & Board committees
      • Management
      • Accounting principles
      • Internal control & Risk management
      • Auditor
      • Articles of association
      • Remuneration

Press releases

All press releases Regulatory

Regulatory press release 2019-12-05

Xspray Pharma contemplates a directed share issue

Press release 2019-11-14

Xspray Pharma publishes Interim Report Q3, January – September 2019

Regulatory press release 2019-10-31

Xspray receives FDA clearance of IND for HyNap-Dasa

Press release 2019-10-04

Xspray – Successful submission of IND application to FDA

Press release 2019-09-10

Xspray aims for up-listing first half of 2020

Press release 2019-08-29

Xspray Pharma publishes Interim Report Q2, January – June 2019

Regulatory press release 2019-06-27

Successful production start for HyNap-Dasa in Xspray’s unique full-scale production line

Regulatory press release 2019-06-11

Xspray granted additional product patents in the United States for HyNap-Sora and HyNap-Nilo

Press release 2019-05-23

Bulletin from the annual general meeting of Xspray Pharma AB (publ)

Press release 2019-05-16

Xspray Pharma publishes Interim Report Q1, January-March 2019

Show more

IR contact

Jacob Nyberg, IRO

+46 (0)70 767 08 83

info@xspray.com

Subscribe

  • This field is for validation purposes and should be left unchanged.
  • Submit to our press releases and get an email every time we publish a press release or report on our website.
  • When clicked on Send I agree that my personal information will be saved. Read more
Xspray-logo-white

Xspray Pharma AB Scheeles väg 2 171 65 Solna

+46 (0)8 730 37 00 info@xspraypharma.com